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Abstract.  Human fibroblasts generate at least eight 
tropomyosin (TM) isoforms (hTM1, hTM2, hTM3, 
hTM4, hTM5, hTM5a, hTM5b, and hTMsmo0 from 
four distinct genes, and we have previously demon- 
strated that bacterially produced chimera hTM5/3 ex- 
hibits an unusually high affinity for actin filaments and 
a loss of the salt dependence typical for TM-actin 
binding (Novy, R.E., J. R.  Sellers, L.-E  Liu, and 
J. J.-C.  Lin,  1993. Cell Motil.  & Cytoskeleton. 26: 
248-261).  TO examine the functional consequences of 
expressing this mutant TM isoform in vivo, we have 
transfected CHO cells with the full-length eDNA for 
hTM5/3 and compared them to cells transfected with 
hTM3 and hTM5.  Immunofiuorescence microscopy re- 
veals that stably transfected CHO cells incorporate 
force-expressed hTM3 and hTM5 into stress fibers 
with no significant effect on general cell morphology, 
microfilament organization or cytokinesis. In stable 
lines expressing hTM5/3, however, cell division is 
slow and sometimes incomplete. The doubling time 
and the incidence of multinucleate cells in the stable 
hTM5/3 lines roughly parallel expression levels. A 
closely related chimeric isoform hTM5/2, which 
differs only in the internal, alternatively spliced exon 
also produces defects in cytokinesis, suggesting that 
normal TM function may involve coordination between 
the amino and carboxy terminal regions. This coordi- 
nation may be prevented in the chimeric mutants. As 
bacterially produced hTM5/3 and hTM5/2 can displace 
hTM3 and hTM5 from actin filaments in vitro, it is 
likely that CHO-expressed hTM5/3 and hTM5/2 can 
displace endogenous TMs to act dominantly in vivo. 
These results support a role for nonmuscle TM iso- 
forms in the fine tuning of microfilament organization 
during cytokinesis. 
Additionally, we find that overexpression of TM 
does not stabilize endogenous microfilaments, rather, 
the hTM-expressing cells are actually more sensitive 
to cytochalasin B. This suggests that regulation of 
microfilament integrity in vivo requires stabilizing fac- 
tors other than, or in addition to, TM. 
N 
'ONMUSCLE cells,  unlike smooth or striated muscle 
cells, express multiple isoforms of  tropomyosin (for 
review see Lees-Miller and Helfman, 1991). The 
generation of tropomyosin  (TM)  ~ isoforms  involves regu- 
lated alternative splicing of  an internal exon, as well as exons 
encoding the terminal "head and tall" regions (Lees Miller 
and Helfman, 1991; Pittenger et al., 1994 for reviews), do- 
mains shown to be essential for muscle TM function in vitro 
(Mak and Smillie,  1981; Hitchcock and Heald 1987; Cho et 
al.,  1990; Bartegi et al.,  1990; Novy et al.,  1993/,). This 
specific pattern of exon use in fibroblasts is conserved be- 
tween human, rat,  and chicken (Novy et al.,  1993c; Pit- 
tenger et al., 1994; Bradac et al., 1989; Libri et al., 1989; 
Forry-Schaudies et al., 1990) and produces two size classes 
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of TM isoforms, low and high molecular weight TMs with 
248 and 284 amino acids (aa),  respectively. 
Representative  isoforms from these two TM classes have 
been shown to have different localization within cultured hu- 
man and chick embryo fibroblasts (Linet al., 1988a), with 
high molec~.~veight TMs associated with the stable stress 
fibers and'Iow molecular weight TMs found on stress fibers 
and in highly motile ruffle regions. In vitro characterization 
of nonmuscle TM isoforms  from human, rat and chicken 
(Lin et al., 1985a,  1988a; Fowler and Bennett,  1984; Mat- 
sumura  and  Yamashiro-Matsumura,  1985; Pittenger and 
Helfman,  1992; Broschat  and  Burgess,  1986) have  also 
shown  isoform-specific  actin-binding  properties.  We have 
reported differences for bacterially produced human fibro- 
blast TM high and low molecular weight isoforms, as well 
as  for chimeric combinations  of high and low molecular 
weight isoforms (Novy et al., 1993a) in their ability to bind 
actin and enhance actin-activated HMM-ATPase activity in 
a manner consistent with the suggestion that low molecular 
weight isoforms may be more involved with regulation  of 
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microfilament protection and organization. This stabiliza- 
tion role for high molecular weight TM was further sug- 
gested by the in vitro findings (Ishikawa  et al.,  1989) that 
high molecular weight TM more effectively protects actin 
filaments from the severing activities of gelsolin than low 
molecular weight TM. Additionally, the down regulation of 
high molecular weight TM in transformed cells is coincident 
with the diminished, poorly organized actin cytoskeleton 
and rounded morphology characteristic of the transformed 
phenotype (Lin et al.,  1984,  1985a; Hendricks and Wein- 
traub, 1981; Cooper et al., 1985). A high-affinity  nonmuscle 
TM was also found to slow the depolymerization  of the actin 
filament pointed end in vitro (Broschat et al., 1989).  There 
has been, however, no direct evidence for a stabilization role 
for TM in vivo, except that a yeast tropomyosin (TPM1) null 
mutant appears  to have less  stable  actin cables  (Liu and 
Bretscher,  1989). 
Correlative data aside, the role of tropomyosin in nonmus- 
ele cells has not been well characterized and even less is 
known about isoform-specific functions. We have studied 
bacterially produced human fibroblast TM isoforms hTM3 
(high molecular weight), hTM5 (low molecular weight) and 
their chimeric isoforms hTM5/3 and hTM3/5,  in vitro, and 
have found that hTM5 binds actin more strongly and am- 
plifies actin-activated HMM-ATPase activity to a greater ex- 
tent than hTM3. The chimeric mutant hTM5/3 has an affinity 
for F-actin that is even greater than that of hTM5 and does 
not demonstrate the salt dependence typical for TM-actin 
binding (Novy et al.,  1993a). 
To more directly study the physiological role of TM in 
vivo, we have separately transfected CHO cells with full- 
length cDNAs encoding tight-binding mutant hTM5/3 and 
wild-type isoforms hTM3 and hTM5.  In this report we de- 
scribe  that,  in  stably  transfected  CHO  cells,  hTM3  and 
hTM5 colocalize with actin filaments, consistent with the 
distribution of endogenous tropomyosin. CHO cells stably 
expressing hTM5/3,  however, sometimes possess disruption 
of F-actin bundles and a significantly increased incidence of 
multinuclearity that is not seen in cells expressing hTM3 
or  hTM5.  Interestingly,  expression  of  chimeric  isoform 
hTM5/2,  which differs from hTM5/3 only in one internal 
exon, also causes a high incidence of multinucleate cells. 
These  results  suggest that nonmuscle TM  participates  in 
microfilament organization and cytokinesis, and that the ter- 
minal head and tail exon-encoded regions are functionally 
coordinated within each tropomyosin. 
Additionally, we report that overexpression of TM iso- 
forms hTM3,  hTM5,  hTM5/3,  and hTM5/2 in CHO cells, 
does not stabilize endogenous microfilaments. In fact, TM 
overexpression renders the cells more sensitive to cytochala- 
sin B, with hTM3 expression having the most pronounced 
effect. This suggests that, although nonmuscle TM has been 
shown to protect actin filaments in vitro (Ishikawa  et al., 
1989a),  microfilament stabilization in vivo likely requires 
other proteins, such as caldesmon. 
Materials and Methods 
Plasmid DNA Constructs 
Full-length cDNAs for human fibroblast TM isoforms  hTM3, hTM5, and 
chimeric isoform  hTM5/3  (Novy et al.,  1993a)  were  subcloned  into the 
XbaI and BamI-II sites (for hTM3) or the XbaI site (for hTMS/3) of pCB6hx, 
a slightly modified version (Warren et al.,  1994) of the eucaryotic  expres- 
sion vector pCB6,  generously  provided  by Dr.  M.  Stinski (University of 
Iowa,  Iowa City,  IA).  The pCIRihx expression vector contains the neo' 
gene,  which allows  for  selection  of stable clones  in G418,  a  synthetic 
neomycin.  Chimeric mutant hTM5/2  was created in the same manner as 
hTM5/3 (Novy et aI., 1993a) with the splicing of the carboxy terminus (aa 
129-284) of hTM2 onto the amino terminal fragment (aa 1-92) of hTM5, 
and was also subcloned into pCB6hx. The resulting recombinant plasmids 
are referred to as pCBhTM3, pCBhTM5, pCBhTM5/3, and pCBhTM5/2 and 
were prepared for the DNA transfections  using Qiagen columns (Qiagen, 
Inc., Chatsworth,  CA.). 
Cell Culture and Transfection 
CHO cells were maintained in DME plus 10% FCS in a humidified incuba- 
tor  at  370C  with  5%  CO2. DNA  transfeetions  were  performed  using 
DOTAP transfection  reagent  as per the manufacturer's  procedure  (Boeh- 
ringer-Mannheim Biochemicals,  Indianapolis,  IN).  Briefly, ceils grown to 
60% confluence on glass coverslips were incubated with the DOTAP-DNA 
mixture in DME for 6 h, and then rinsed and restored to DME plus 10% 
FCS.  To  select  stable transfectants,  (3418 at 500 #g/rnl (GIBCO BRL, 
Gaithersburg,  MD) was added to the media 48 h after the transfection.  Ceils 
surviving  2 wk of selection were cloned, expanded and screened for expres- 
sion by immunofluorescence  and Western blotting.  For each TM isoform 
studied,  a G418-resistant,  non-hTM-expressing line was selected to serve 
as a negative control, and at least three lines expressing  low to high hTM 
amounts  were  selected  to  identify  hTM  expression-related  effects. The 
stable lines used  in this paper  are,  in order of increasing  expression, 
hTM3C32,  hTM3CI$,  hTM3C36  and  hTM3C73  for  hTM3,  hTM5C2, 
hTM5Cll, hTM5C8, and hTM5CI4 for hTM5, hTM5/3C68,  hTM5/3C36, 
hTM5/3C25  and hTM5/3CT0  for hTM5/3,  and hTM5/2C1,  ~TM5/2C$, 
hTM5/2C20 and hTM5/2C26 for hTM5/2. 
Antibodies and Phalloidin 
Monoclonal antibody CG~6,  generated against  chicken gizzard  TM and 
characterized previously  (Lin et al.,  1985b, 1988a),  recognizes an epitop¢ 
in the COOH-terminal exon region of hTM3 and hTM2. It does not cross 
react with CHO TM and therefore was used to detect hTM3, hTM5/3, and 
hTM5/2 in the transfected  CHO cells. Anti-caldesmon antibody, C21, de- 
scribed previously  (Linct al.,  1988b, 1991), was used at 250-fold dilution 
to recognize endogenous CHO caldesmon.  Anti-TM4 antibody, LC24, was 
generated against bacterially produced  hTM4 (COOH-terminal half), and 
anti-TM5 antibody,  LC1, was generated from bacterially  produced hTM5 
(NH2-tenninal half), following described procedures  (Lin et al.,  1985b). 
LC24 cross-reacts strongly with hTM4, and LC1 with hTM5, as determined 
by ELISA and Western blotting. LC24 recognizes only CHO TM4 in immu- 
noblots.  Another anti-TM5 antibody,  CG3 was characterized previously 
(Lin et al., 1985b, 1988a). CG/~6  and CG3 are IgM class antibodies; LC24, 
LC1, and C21  are IgG class.  Rhodamine-phalloidin  was purchased from 
Molecular Probes (Eugene,  OR) and used at a fourfold dilution in DME 
plus 5 %  FCS. DAPI (4',6'-diamidino-2-phenylindole;  Sigma Chem. Co., St. 
Louis, MO) was used at 0.5 ~tg/ml  and applied as in Lourim and Lin (1992). 
Iramunofluorescence  Microscopy 
Cells grown on glass coverslips were fixed, permeabilized,  and prepared for 
immunofluorescence  microscopy  much  as  described  (Warren  and  Lin, 
1993).  Secondary  antibodies included FITC-conjugated  goat anti-mouse 
IgG (7  chain-specific;  Sigma  Chem.  Co.),  FITC-conjugated  goat anti- 
mouse IgM (/~ chain-specific; Sigma Chem. Co.) and Rhodamine-conjngated 
goat anti-mouse IgM (# chain-specific; Cappel/Organon-Teknika,  Durham, 
NC).  Micrographs were taken with a Zeiss epifluorescence  photomicro- 
scope Ill. 
Western Blot Analysis 
Cells at 90 % confluence were harvested and extracts processed as described 
previously  (Warren et al.,  1994).  After separation by 12.5%  SDS-PAGE, 
resolved proteins were transferred to nitrocellulose  and immunoblotted as 
in Lin et al. (1985b). Amido black staining was used to demonstrate relative 
protein loading. 
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Determination of the endogenous and force-expressed TM levels reported 
in Table 1, was performed as described (Warren et al., 1994). Autoradio- 
graph images from CG/36, LC1, CG3, and LC24 immunoblots were col- 
lected with a Hamamatsu CCD camera, model XC77, with camera con- 
troller C2400 (Hamamatsu, Hamamatsu City, Japan) and analyzed using 
the Image-l/AT image processing and analysing system, version 4.13 
(Universal Imaging Corporation, Westchester, PA). Intensity values of 
CGB6, LCl, CG3, or LC24 autoradiograph bands from known amounts of 
purified, bacterially produced hTMs were used to construct standard 
curves, against which the CG/56, LC1, CG3, or LC24 bands from the hTM- 
expressing lines were measured. Total protein concentration was measured, 
prior to blotting, as described by Lowry et al. (1951). 
Other Cell Culture Procedures 
"Mitotic shake off" (MSO) was performed as in Mariani et al. (1981). 
Briefly, a culture dish containing cells at 80% confluence was held in one 
hand and knocked sideways into the palm of the other hand. The loosened 
cells were drawn off the monolayer, centrifuged, and quickly replated in a 
35 mm dish. 
Cytochalasin B treatment involved incubation of cells grown on glass 
coverslips in media containing 1.0, 1.25, or 1.5/~g/ml cytochalasin B for 30 
mins at 37°C. As cytochalasin B was dissolved in DMSO prior to addition 
to the media, control cells were exposed to DMSO alone. After treatment, 
cells were processed for immunoflourescence microscopy with CG3, LC24, 
or rhodami~e-phalloidin to demonstrate the extent of microfilament dis- 
ruption. 
Actin Binding Assay 
The actin binding-competition assay was based on the cosedimentation 
method of Eaton et al. (1975) and was performed as described (Novy et al., 
1993a) using a Beckman airfuge rotor A-100/18. F-actin was purified from 
the acetone powder of rabbit skeletal muscle (Spudich and Watt, 1971) and 
bacterially produced hTMs were purified as described (Novy et al., 1993a). 
Reaction mixtures contained 9.4 #M actin and 2.0 mM hTM3 or hTM5 in 
F buffer (10 mM imidazole buffer, pH 7.0, 100 mM KCI, 10 mM MgCI2, 
0.1 mM EGTA, and 1 mM DTT) with competitors hTM5/3 or hTM5/2 in 
varying amounts up to 2.1/zM. The resulting bound and free fractions were 
analyzed and quantified as described previously (Novy et al., 1993a). 
Table L Level of TM Expression in Selected Stable Lines* 
Percentage of total protein: 
Cell line Force-expressed hTM Endogenous TM4 
hTM3C32 0.000 + 0.000 0.033 + 0.001 
hTM3C15 0.033 + 0.013 0.026 + 0.004 
hTM3C36 0.050 + 0.002 0.024 + 0.001 
hTM3C73 0.050 + 0.002 0.022 + 0.003 
hTM5C2 0.028 + 0.028* 0.029 -1- 0.002 
hTM5Cll 0.071 + 0.005* 0.023 + 0.002 
hTM5C8 0.075 + 0.002* 0.028 + 0.008 
hTM5C14 0.214 5: 0.014' 0.026 + 0.002 
hTM5/3C68 0.000 + 0.000 0.029 + 0.016 
hTM5/3C36 0.024 + 0.002 0.022 + 0.005 
hTM5/3C25 0.030 + 0.008 0.030 + 0.010 
hTM5/3C70 0.092 + 0.004 0.033 + 0.004 
hTM5/2C1 0.000 + 0.000 0.025 + 0.006 
hTM5/2C5 0.010 + 0.001 0.029 + 0.000 
hTM5/2C20 0.037 + 0.000 0.024 + 0.001 
hTM5/2C26 0.037 + 0.001 0.026 -t- 0.003 
* Values shown for the hTM3, hTM5/3, and hTM5/2 lines are the average 
values from two independent experiments. 
* Since the LCI antibody crossreacts to both endogenous CHO TM5 and force- 
expressed hTM5, the amounts of hTM5 expression were calculated by substracting 
the amounts of endogenous TM5 in CHO line from the total TM5 amounts de- 
tected by LC1 antibody in each of hTM5 expressing lines. 
Equivalent results were obtained whether the competitors were added at the 
same time or after a 30-rain incubation with hTM3 or hTM5 isoform. 
Results 
Our previous characterization, in vitro, of bacterially pro- 
duced human fibroblast hTM3, hTM5, and their chimeras 
hTM3/5 and hTM5/3 (Novy et al., 1993a) revealed that the 
isoforms had distinct functional properties, including the 
ability to bind actin, to amplify actomyosin ATPase activity 
and to interact with caldesmon. To study the function of TM 
in the nonmuscle cell and to ascertain whether the isoform- 
specific properties seen in vitro are physiologically relevant, 
we expressed hTMs in CHO cells with DNA transfection. 
We focused on isoform hTM5/3, because of its extreme actin 
binding properties, and hTM3 and hTM5, for comparison, 
as they are the wild-type "parent" isoforms. Full length 
cDNAs for hTM5/3, hTM5, and hTM3 were separately 
subcloned into eucaryotic expression vector pCB6hx, sep- 
arately transfected into CHO cells, and assayed for expres- 
sion 18-24 h after transfection, via immunofluorescence mi- 
croscopy. Transient expression of hTM5/3, but not hTM3 or 
hTM5, resulted in severe distortions of the transfected cell 
shape and a disruption of F-actin bundles (data not shown). 
We have previously found that shape change is not routinely 
found with transient expression of other proteins such as 
actin-binding "CAD39" or non-actin-binding "CAD40" frag- 
ments of human fibroblast caldesmon (Warren et al., 1994). 
Mismatched Terminal "Head and Tail" 
Domains Appear to be Responsible for the Disruptive 
Effects of hTMS/3 
Fig. 1 shows a cartoon representation of the isoform-specific 
domains of hTM3 and hTM5 that are "mismatched" in chi- 
meric mutant hTM5/3. Note that the sequence diversity is 
restricted to the exon-encoded regions of the termini as 
well as one internal domain. To determine whether the mis- 
matched termini or the internal exon region are primarily 
responsible for the altered properties of hTM5/3, we took ad- 
vantage of the fact that a chimera between hTM5 and hTM2, 
hTM5/2, differs from hTM5/3 solely in that internal region 
(Fig. 1). We therefore constructed a hTM5/2-containing ex- 
pression plasmid and transfected it into CHO cells. The 
hTM5/2-transfected cells demonstrated the same range of 
aberrant morphologies as seen with transient hTM5/3 ex- 
pression (data not shown). Additionally, the actin binding 
properties of bacterially produced hTM5/2, purified and 
analyzed as in Novy et al. (1993a), were similar to those of 
hTM5/3 (data not shown). Therefore, the internal exon does 
not seem to be the primary cause for the dominant effects of 
hTM5/3 on cell shape and microfilament organization. 
Stable Expression of hTMs Does Not Alter Endogenous 
Levels of TM or Caldesmon 
To more closely analyze the effects of hTM5/3, hTM5/2, 
hTM5 and hTM3 overexpression, we obtained clonal lines of 
permanently transfected cells and determined their relative 
expression levels by western blot analysis. As our stably 
transfected cells were the result of random integration of the 
hTM- and neo'-containing vector, we aimed to select and 
characterize several independent stable lines each, of hTM3, 
hTM5, hTM5/3, and hTM5/2, to rule out non-TM, position- 
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cDNAs  for  lfrM3,  lffM2,  hTM5, and  the  chimeric  isoforms 
hTM5/3 and hTM5/2. The alternatively spliced exon regions are 
differently  shaded to show the areas of isoforrn  diversity. Chimeric 
isoforms hTM5/3 and hTM5/2 differ solely in the region encoded 
by the internal alternatively spliced exon (arrow). 
effect, phenotypes. Although the effects of transient transfec- 
tion of hTM5/3 and hTM5/2 were often severe, we were able 
to obtain and expand a few clonal lines expressing different 
levels  of hTM5/3 and hTM5/2,  as well as stable lines ex- 
pressing hTM3 or hTM5. A quantitative analysis of hTM ex- 
pression levels from Western blots of the selected hTM lines 
is shown in Table I. The protein concentrations for each cell 
line extract were determined, known amounts of  extract were 
subjected to immunoblotting, and the autoradiographs were 
analysed as described in the Materials and Methods section. 
Table I shows that the amount of hTM overexpression in the 
selected stable lines ranged from approximately one to three 
times that of endogenous TM4 levels,  except for the high- 
expresing hTM5C14.  It is also important to note that steady 
state levels of endogenous TM4, which ranged from 0.020 
to 0.033%  of total protein in the negative control lines, did 
not show hTM-expression-related changes in the lines that 
express hTM3,  hTM5,  hTM5/3,  or hTM5/2. 
Representative Western blots showing hTM, endogenous 
TM4, as well as endogenous caldesmon levels are shown for 
the hTM5/3 lines in Fig. 2, for the hTM3 and hTM5/2 lines 
in Fig. 3, and for the hTM5 lines in Fig. 4. The CG/~6 immu- 
noblot of Fig. 2 A, shows hTM5/3C36 (lane 2), hTM5/3C25 
(lane 3), and hTM5/3C70 (lane 4), the hTM5/3 lines chosen 
to represent low to high expression levels, as well as the 
drug-resistant non-expressor, hTM5/3C68 (lane l). Fig. 3 
A, shows the hTM3 expression levels among the hTM3 stable 
lines, hTM3C15 (lane 2), hTM3C36 (lane 3), and hTM3C73 
(lane 4) and nonexpressor control line, hTM3C32 (lane 1 ). 
A CG/~6 blot of the hTM5/2 lines is shown in Fig. 3 E, with 
the negative control line hTM5/2C1  in lane 1 and hTM5/2- 
expressing lines, hTM5/2C5, hTM5/2C20 and hTM5/2C26 
shown in lanes 2-4, respectively. The amido black-stained 
panels  (Figs.  2  D,  and  3  D  and H)  and  the Coomassie 
blue-stained gel panel (Fig. 4 A) demonstrate relative total 
protein  loading.  Since the LC1  antibody recognizes both 
endogenous CHO TM5  and exogenously force-expressed 
hTM5, the LC1 immunoblot shall demonstrate the combined 
amounts of CHO TM5 and hTM5. In Fig. 4 B, the hTM5 sta- 
ble lines, hTM5C2 (lane 2), hTM5Cll  (lane 3),  hTM5C8 
(lane 4), and hTM5C14 (lane 5) appear to represent low to 
high expression levels of hTM5.  The level of expression in 
hTM5C2 (Fig. 4+B, iane 2) was not significantly different 
from that in the original CHO line (Fig. 4 B, lane 1 ). Thus, 
the hTM5C2 may represent a drug-resistant hTM5 nonex- 
pressor. 
We previously reported that overexpression of the actin-, 
Ca2+/calmodulin  -, and TM-binding fragment of human fibro- 
blast caldesmon, CAD39, increased the steady-state levels of 
endogenous TM. This was not due to an increase in TM syn- 
thesis, but to a reduction in TM turnover, presumably result- 
ing from CaD39-enhanced TM-actin binding (Warren et al., 
Figure 2. Western blot analy- 
sis  of hTMS/3 stable  lines, 
hTM5/3C68 (lane I), hTM5/ 
3C36  (lane 2),  hTM5/3C25 
(lane  3),  and  hTM5/3C70 
(lane 4). The blots were run in 
triplicate to show the level of 
lfl'M5/3 expression  with CG/~6 
antibody (A), the endogenous 
caldesmon level with C21 an- 
tibody (B), and the level  of  en- 
dogenous  TM4 with LC24 an- 
tibody (C). The amido black- 
stained panel (D)  shows the 
total protein loadings. Control 
line  hTM5/3C68  has  no 
hTM5/3 expression (A,  lane 
1)  whereas  hTM5/3C36, 
hTM5/3C25 and hTM5/3C70 
have increasing  hTM5/3  levels 
(.4, lanes  2-4). Note  that there 
is no apparent  hTMS/3 expres- 
sion-related chan  tre ill the en- 
dogenous  caldesmon (B, lanes 
1-4) or TM4 (C, lanes 1-4) of 
these stable lines.  TM4, en- 
dogenous TM4; CaD, endog- 
enons caldesmon. 
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of hTM3 (A-D)  and  hTM5/2 
(E-H)  stable  lines.  The  ex- 
perimental  design is much like 
that  of Fig.  2.  D  and  H  are 
amido black-stained panels  to 
demonstrate total protein load- 
ings for the hTM3 and hTM5/2 
lines,  respectively. CG~6 anti- 
body  was  used  to  detect  the 
level of hTM3 (A) or hTM5/2 
(E)  expression.  Endogenous 
CaD levels were  probed  with 
C21  antibody  (B and  F)  and 
CHO TM4 levels were probed 
with LC24 antibody (Cand G). 
There is no reproducible differ- 
ence  in the  steady state  levels 
of CHO  CaD  or  CHO  TM4 
between the four hTM3 stable 
lines (lanes 1-4 of B and C) or 
the  four  hTM5/2 lines  (lanes 
1-4 ofFand G). TM4, endoge- 
nous  TM4;  CaD,  endogenous 
caldesmon. 
1994). We were, therefore, curious as to whether the overex- 
pression of TM would change caldesmon levels. The West- 
ern blots in  Figs.  2-4 with anti-caldesmon antibody C21 
(Figs. 2 B, 3 B and F, and 4  C) show that steady-state levels 
of caldesmon remain unchanged in cells expressing various 
amounts of hTM5/3, hTM3, bTM5, or hTM5/2. Endogenous 
levels of TM4 also appear undisturbed in the LC24 immuno- 
blots of the lines expressing hTM5/3 (Fig. 2 C), hTM3 (Fig. 
3 C) or hTM5/2 (Fig. 3 G) or hTM5 (Fig. 4 D). CHO TM5 
levels in hTM5/2, hTM5/3, and hTM3 lines also remain con- 
stant  (data  not  shown).  It  appears  that  force-expressed 
hTM5/3, hTM5/2, hTM3, and hTM5 do not appreciably alter 
the accumulation of endogenous CHO TM or caldesmon. 
The transfected, hTM-expressing, cells then possess unusual 
total TM to caldesmon ratios. 
Stable Chimeric Mutant hTM Lines Have Cell 
Cycle-dependent Heterogeneous Expression Levels 
All viable hTM5/3-expressing lines that we were able to iso- 
late and expand from single clones have the peculiar trait of 
heterogeneous cell-to-cell expression levels as determined 
Figure 4. Western blot analy- 
sis of CHO line (lane 1), and 
hTM5  stable  lines,  hTM5C2 
(lane  2),  hTM5Cll  (lane 
3),  hTM5C8  (lane  4),  and 
hTM5CI4  (lane  5).  The ex- 
perimental  design  is  much 
like that of Fig. 2.  The blots 
were run in triplicate to show 
the level of endogenous CHO 
TM5  and  hTM5 with  LC1 
antibody (B), the endogenous 
caldesmon  (CAD) with  C21 
antibody (C), and the level of 
endogenous TM4 with LC24 
antibody (D). The Coomassie 
blue-stained gel (A) shows the 
total  protein  loadings.  The 
amount  of  CHO  TM5  and 
hTM5 expressed in the hTM- 
5C2 (B, lane 2) is not signifi- 
cantly  different  from that  in 
CHO  line  (B,  lane  1).  The 
hTM5C2 line may, therefore, represent a nonexpressor line. On the other hand, hTM5C11, hTM5CS, and hTM5CI4 lines express increasing 
levels of hTM5. There is no significant difference in the steady-state levels of CHO CaD and CHO TM4 between the four hTM5 stable 
lines (lanes 2-5 of C and D). 
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cence staining in Fig. 5 A demonstrates that cells of hTMS/3 
representative expressing line, hTM5/3C70,  have different 
levels of expression as judged by relative CG/36 staining in- 
tensities. Four very weakly stained cells have been outlined 
and marked with asterisks in Fig. 5 A.  The heterogeneous 
CG/36 intensities appear to be linked to the cell cycle because 
cells from all hTM5/3 lines brightly and evenly stain with 
CG/36 after synchronization by mitotic shake off (Fig. 5 B). 
Homogeneous staining remains until cells lose their mitotic 
synchrony, at about 18 h in culture (data not shown). Hetero- 
geneous CG/36 staining intensities are also seen with stable 
hTM5/2 lines but not with IaTM3 lines. The homogeneous 
CG/36 staining of hTM3C73, a representative high express- 
ing line is shown in Fig.  5  C. 
Stable Expression of hTMS/3 and hTM5/2 Perturbs 
Cytokinesis in CHO Cells 
Most cells of the hTM5/3 stable lines have a relatively "nor- 
mal" morphology. Of the aberrant cells, some have abnormal 
shapes  similar  to  the  transiently transfected cells but the 
majority are huge with many nuclei. We found, upon com- 
parative cell counting, that the incidence of multinuclearity 
increased  relative to hTM5/3  expression (Table II).  Cells 
were judged to be multinucleate if at least three nuclei were 
discernible.  Fig.  6  shows  DAPI-stained  nuclei from non- 
expressing  hTM5/3C68  (Fig.  6  A)  and  expressing  line 
hTM5/3C25 (Fig. 6 B), as examples. The nuclei in the af- 
fected  cells  were  often  bunched  together,  therefore,  the 
counts included in Table II may even underestimate the per- 
cent nuclei in multinucleate cells. The multinucleate popula- 
tion in hTM3- or hTM5-expressing cell lines was not sig- 
nificantly different from that of the non-expressing control 
lines or for CHO cells alone.  Expression of the hTM5/3- 
related chimera hTM5/2, however, did result in an increased 
incidence of multinucleate cells related roughly to the level 
of hTM5/2 expression. 
The  greatly  increased  presence  of multinucleate  cells 
specifically in the hTM5/3 and hTM5/2 lines is a good indi- 
cation that these chimeric mutant hTMs can interfere with 
successful cytokinesis. We therefore sought to understand 
the  mechanism  of the  cytokinesis defect by  studying  the 
hTM-expressing cells which do make it through cell divi- 
sion.  As  early  as  the  initial  cloning  of the  hTM5/3  and 
hTM5/2 lines we noticed a decrease in the growth rates that 
corresponded to the level of the chimeric hTM expressed. 
Control line hTM5/3C68 cells doubled in 15 h. The doubling 
times for hTM5/3C36, hTM5/3C25, and hTM5/3C70 were 
17,  17,  and  24  h,  respectively, hTM5/2-expressing  stable 
lines also grow more slowly than nonexpressing stable lines, 
but stable CHO lines expressing hTM3, hTM5, or caldesmon 
fragments  do  not have  expression-related effects on their 
growth rates (data not shown). 
To  try  to  define  the  cell  cycle period  involved in  the 
hTM5/3-related defect, we synchronized the cells for using 
MSO. This technique allows for the selection of cells which 
have rounded up for division without the addition of cyto- 
skeletal-altering drugs.  MSO cells from the hTM5/3 lines 
were collected, replated on coverslips and observed. After 
replating, mitotic cells completed cell division by pinching 
into two distinct, small, jtixtaposed ceils we refer to collec- 
tively as a  doublet.  CHO cells and nonexpressing hTM5/ 
Figure 5.  Immunofluorescence microscopy on ceils  from stable 
hTM5/3 (A and B) or hTM3 (C) lines with CG/56. (A) All hTMS/3 
lines, when cultured asynchronously,  exhibit heterogeneous cell-to- 
cell CG/36 staining 0aTM5/3CT0  cells shown). Four weakly stain- 
ing cells are partially outlined and marked with asterisks. (B) CG/36 
staining levels  are more homogeneous  after hTM5/3-expressing  cells 
are synchronized (hTM5/3C70 cells shown, 4 h after mitotic shake 
off).  (C)  hTM3 stable  lines  have uniform  staining  with  CG/36 
regardless of cell cycle state. Bar, 10 #m. 
3C68 cells were very quick to divide and 20 min after replat- 
ing, 35.4% of hTM5/3C68 cells were doublets, whereas only 
17.7, 13.7, and 7.9% of TM5/3C36, hTM5/3C25, and hTM5/ 
3C70 cells were doublets (Table III). As stable line expres- 
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Relative  Percentage in 
expression  Total nuclei  multinucleate 
Cell line  level  counted  cells 
CHO  -  1,206  0.91 
hTM3C32  -  1,229  0.49 
hTM3C 15  + +  1,204  0.83 
hTM3C36  + + +  1,211  0.58 
hTM3C73  + + +  1,306  0.54 
hTM5C2  -  1,119  0.54 
hTM5C11  + +  1,108  0.90 
hTM5C8  + + +  1,091  2.47 
hTM5CI4  + + + + +  1,079  3.80 
hTM5/3C68  -  1,257  1.03 
hTM5/3C36  + +  1,238  6.70 
hTM5/3C25  + +  1,256  7.25 
hTM5/3C70  + + + +  1,340  24.78 
hTM5/2C 1  -  1,060  0.92 
hTM5/2C5  +  1,328  5.21 
hTM5/2C20  + +  1,005  9.52 
hTM5/2C26  + +  1,446  15.77 
* Criteria: cells possessing ~3  nuclei =  multinucleate. 
sion levels of hTM5/3 increased the time it took to pinch in 
half was also increased. This phenomenon was also seen in 
cells expressing hTM5/2, but not for cells of the hTM3 or 
hTM5 lines (data not shown). These results indicate that this 
phase  of cell division is  somehow slowed by hTM5/3  or 
hTM5/2. The actin-based contractile ring is formed and uti- 
lized during this phase (Satterwhite and Pollard, 1992 for re- 
view), so it is possible that hTM5/3 or hTM5/2 are interfer- 
ing with contractile ring formation and/or usage. In the yeast 
S. pombe,  TM has already been found to be required for 
cytokinesis and the formation of the contractile ring (Bala- 
subramanian et al.,  1992). 
We are currently investigating, in vitro, the interactions of 
hTM isoforms with actin binding, bundling and severing pro- 
teins as well as with actin itself, in the hope that this informa- 
tion will help further define the role of the chimeric mutants 
in  the  division defect and,  ultimately, the role of TM  in 
cytokinesis. We have previously characterized the in vitro 
actin-binding  properties  for  bacterially  produced  hTM5, 
hTM3 and hTM5/3 (Novy et al., 1993a). In this study, using 
an actin-binding assay,  we have found that bacterially pro- 
duced hTM5/3 and hTM5/2 can efficiently displace hTM3 
and hTM5 from actin filaments (Fig. 7). Under the satura- 
tion-binding condition with 9.4 #M actin and 2.0 #M hTM5, 
chimera hTM5/2 or hTM5/3 at 1.3/zM was able to compete 
off about half of the prebound hTM5 from actin filaments 
(Fig. 7 A). Similarly, both hTM5/2 and hTM5/3 were found 
to be very effective competitors for the hTM3 too (Fig. 7 B). 
Interestingly,  it appeared  that  less  amounts  (0.75  #M)  of 
hTM5/3 was required for displacing 50% of hTM3 from ac- 
tin  filaments,  as  compared to the  requirement of 1.3  /~M 
hTM5/2 (Fig. 7 B). This difference may be reflected by the 
difference in  amino acid  sequences between hTM5/2 and 
hTM5/3. The dominance of chimeric TM actin binding, in 
vitro, suggests that hTM5/3 and bTM5/2 may be able to exert 
their isoform-specific effects on CHO filament structure by 
displacing the endogenous TM. 
hTM Overexpression  Does Not Stabilize 
CHO Microfilaments 
Nonmuscle TM has been proposed to stabilize actin-based 
filaments (Lin et al., 1984, 1985a; Hedricks and Weintraub, 
1981; Leavitt et al.,  1986; Cooper et al.,  1985; Broschat et 
al., 1989; Tanaka et al., 1993) and protect them from sever- 
ing agents such as gelsolin (Fattoum et al.,  1983; Ishikawa 
et al., 1989) and villin (Bonder and Mooseker, 1983). These 
proposals were based on the fact that TM isoforms are down 
regulated  in  stress  fiber-deficient transformed  cells  and 
also based on results from in vitro experiments. Our hTM- 
expressing lines provide an ideal environment in which to 
directly test the stabilization hypothesis, in vivo. After treat- 
ment of hTM5/3,  hTM5/2,  hTM5,  and hTM3  stable lines 
with cytochalasin B, a fungal toxin which disrupts F-actin, 
we observed that the actin filament bundles of hTM-express- 
ing cells were actually less resistant to treatment than those 
of non-hTM-expressing cells. Fig. 8 shows the extent of  dam- 
age to the TM-containing microfilaments in hTM3 cells ex- 
posed to 1.0 t~g/ml cytochalasin B. The CG3-stained TM-con- 
taining stress fibers are still intact in nonexpressor hTM3C32 
(Fig.  8  A),  but  show  gradual  disruption  in  the  low  and 
medium level lines hTM3C15 (Fig. 8 B) and hTM3C36 (Fig. 
8  C),  with only brightly staining aggregates remaining in 
high-expressor line hTM3C73 (Fig. 8 D). Cells stained with 
phalloidin  to visualize F-actin  (data  not  shown)  revealed 
identical patterns of filament disruption, hTM5, hTM5/3-, 
and hTM5/2-expressing lines  were also more sensitive to 
cytochalasin B than non-expressing lines (data not shown). 
The destabilization of actin bundles in cells overexpressing 
TM is a new finding that implies that TM alone in vertebrate 
nonmuscle cells cannot fully protect actin filaments. 
Discussion 
The functions of TM in the nonmuscle cell have yet to be 
definitively assigned. Suggestions that nonmuscle TM is in- 
volved in  the  regulation  of microfilament dynamics have 
been based on in vitro observations that nonmuscle TM can, 
when bound to F-actin, modulate the actions of other actin- 
binding proteins which sever (Fattoum et al., 1983; Ishikawa 
et al.,  1989),  bundle  (Burgess et al.,  1987),  or stabilize 
(Ishikawa et al., 1989) actin filaments. In vivo, much less has 
been done  to  directly test nonmuscle TM  function.  The 
down regulation of TM isoforms in transformed cells corre- 
lates well with the decrease of obvious microfilament bun- 
dles (Lin et al. 1984, 1985a; Leavitt et al., 1986) and forced 
reexpression of TM in ras transformed cells has been re- 
ported to partially restore stress fibers (Prasad et al., 1993). 
Microinjection studies with anti-TM antibodies have impli- 
cated TM in granule movement (Hegmann et al.,  1989) and 
TM assembly properties have been investigated with micro- 
injection of  recombinant TMs (Pittenger and Helfman, 1992). 
Finally, yeast genetic analyses have shown TM to be essen- 
tial for actin cables in Saccharomyces cerevisiae (Liu and 
Bretscher,  1989)  and  cytokinesis in Schizosaccharomyces 
pombe (Balasubramanian et al., 1992). In this study, we have 
further approached the question of nonmuscle TM function 
using DNA transfection to express human fibroblast TMs 
and their chimeric mutants in CHO cells, and we report here 
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days on coverslips were stained with 
DAPI to demonstrate the increased 
incidence of multinucleate cells  in 
hTM5/3-expressing lines. (,4) Nega- 
tive  control  line  hTM5/3C68. (B) 
High-expressing  line  hTM5/3C70. 
Bar, 10/zm. 
that expression of chimeric mutant hTM isoforms can per- 
turb cytokinesis. 
Why do the chimeric hTM isoforms behave so differently 
from the parent TM isoforms in vitro and in these transfec- 
Table IlL Percent of Doublet Cells After Mitotic  Shake Off 
Percent doublets 
after plating* 
Relative 
expression  Total  20  40  60 
Cell line  level  counted  min  min  min 
hTM5/3C68  -  1,045  35.4  39.4  44.8 
hTM5/3C36  +  +  970  17.7  34.8  38.8 
hTM5/3C25  +  +  1,660  13.7  26.6  28.4 
hTM5/3C70  +  +  +  +  1,891  7.9  22.8  32.9 
* Percent doublets never reach 100% due to the significant number of cells which 
divide during the shake off.  These small single cells are one half the size of 
a doublet. 
tion experiments? It has been suggested that the amino and 
carboxy terminal regions are required for TM-TM interac- 
tions  and  that both terminal  regions are the major deter- 
minants of muscle TM function (Cho et al.,  1990; Cho and 
Hitchcock De-Gregori, 1991). Our previously reported data 
that, in vitro, chimeric hTM5/3 displays actin binding prop- 
erties distinct from those of hTM5 or hTM3, suggests that in- 
teractions between the N and C halves of an individual TM 
are  important  for  TM  function  (Novy  et  al.,  1993a). 
hTM5/2, the closely related chimeric isoform (see Fig.  1), 
has  actin-binding  properties similar  to  hTM5/3  (data  not 
shown), further indicating that the mismatch of the terminal 
exon-encoded regions  is  responsible  for  the  altered  TM 
properties. Analysis of  muscle TM crystal structure (Phillips 
et al., 1986; Sanders et al., 1988) predicts that TM is a flexi- 
ble molecule with at least three conformational states. The 
amino half is reportedly more stable; the carboxy half more 
labile, especially in a segment around cys 190 (Phillips et al., 
1986). We have previously proposed that a functional con- 
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Figure 7. Competitive actin-binding assay with bacterially produced 
i'frM3, hTM5, hTM5/2, and hTM5/3. The reaction mixtures con- 
tained 9.4/~M actin, and 2.0/~M of hTM5 (A) or lffM3 (B) in F 
buffer (10 mM imidazole buffer, pH 7.0, 100 mM KCI, 10 mM 
MgCI2, 0.1 mM EGTA, and 1 mM DTT). After incubation for 30 
min at room temperature,  various concentrations of competitors 
(hTMS/2 or hTMS/3) were added to the mixtures. After additional 
30-min incubation, the mixtures were centrifuged at 26 psi for 20 
min in a Beckman airfuge. Both supernatants and pellets were ad- 
justed  to equivalent volumes and analyzed by SDS-PAGE. The 
binding of  hTM5 or hTM3 was determined by scanning stained gels 
of both supernatants and pellets. The amount of hTM5 or hTM3 
bound to actin filaments in the absence of competitors was used as 
100%. Data were obtained from 3 independent experiments with 
error bars representing standard deviations. Under this saturation 
condition, the prebound hTM5 (,4) and hTM3 (B) were effectively 
competed off from actin filaments by chimera hTM5/2 or hTM5/3. 
formation change exists in an analogous region in nonmuscle 
TM (Hegmann et al.,  1988).  It is possible then,  that the 
specific combination of stable amino and labile carboxy ter- 
minal regions determines the range of conformational flexi- 
bility and also,  perhaps,  function. Analysis of the crystal 
structure of hTMS/3 may allow us to see if the inherent flexi- 
bility for hTMS/3 differs from that reported for striated or 
smooth muscle TM (Phillips et al.,  1986;  Sanders et al., 
1988). 
One interesting feature of the stable hTMS/3 and hTMS/2 
lines is that, although they were derived from single cells, 
they exhibit heterogeneous staining for hTMS/3 or hTMS/2 
with CG/36 antibody (see Fig. 5 A for hTMS/3). The cell to 
cell difference is not likely a property of the CG/36 antibody, 
since CG~6 staining of the hTM3 lines is homogeneous (Fig 
5  C).  Also,  the  CG/36  staining  intensity  of hTMS/3  or 
hTM5/2 lines can be evened out by synchronizing the cells 
(see Fig, 5 B for hTM5/3), suggesting  that detectable hTMS/3 
or hTMS/2 levels are regulated in a cyclic manner. The fact 
that all viable hTMS/3 and hTMS/2 we were able to maintain 
have this heterogeneity, and that lines expressing hTM3 (Fig 
5 C), mouse/3 skeletal TM (Warren and Lin, 1993), and that 
caldesmon fragments CAD39 or CAD40 (Warren et al., 1994) 
do not, further suggested that the chimeric hTM lines that 
survived, may have done so because they regulated the timing 
of the synthesis, degradation, or distribution of the hTM5/3 
or hTMS/2 with the cell cycle. Two other indications that the 
progression through the cell cycle might be sensitive to chi- 
meric hTM expression come from our observations that sta- 
ble line growth rate decreased with increased expression of 
hTM5/3  or hTMS/2,  but not with  increased levels of ex- 
pressed hTM3 or hTM5 (not shown) and that the incidence 
of  multinucleate cells increased roughly parallel to increased 
expression levels of hTM5/3 or hTM5/2 (Table II). 
Cytokinesis involves a  massive remodeling of the actin 
cytoskeleton, with both de novo filament synthesis and actin 
filament redistribution to the cleavage furrow (Cao and Wang 
1990 a,b;  Fishkind  and  Wang,  1993)  but little is  known 
about the mechanism of contractile ring assembly and func- 
tion (for review see Satterwhite and Pollard,  1992). Impor- 
tant information is emerging, however, from analyses of cell 
cycle defective mutants in yeast. Of special interest is the 
identification of cdc8  ÷ as a  novel tropomyosin found to be 
essential for the formation of the F-actin contractile ring in 
S. pombe (Balasubramanian et ai.,  1992). We are interested 
in determining whether TM is involved in contractile ring 
function in higher eucaryotes and are therefore closely ex- 
amining the chimeric hTM cytokinesis defect. The fact that 
the isolated mitotic cells from chimeric hTM lines are slow 
to pinch in two (Table III) may be an indication that ring as- 
sembly kinetics or contraction may be altered. That cytoki- 
nesis appears to be the process most affected by stable ex- 
pression of chimeric hTMs may  suggest that  ring  forma- 
tion requires an isoform-specific function that hTM5/3 or 
hTMS/2 do not possess,  or that the crucial timing of ring 
assembly,  function and  disassembly  is  not achieved with 
hTM5/3 or hTM5/2.  For example, it has been shown that 
tropomyosins of different association constants differentially 
stabilize the pointed end of actin filaments from disassembly 
(Broschat et ai.,  1989). From our in vitro studies, we know 
that both hTM5/2 and hTM5/3 have unusal high affinity to 
actin filaments (Novy et al.,  1993a). This may suggest that 
chimeric tropomyosins in the contractile rings may be capa- 
ble of slowing down the disassembly of actin filaments and 
then, lead to a defect in cytokinesis. Other cell activities in- 
volving TM function may not have such strict temporal re- 
quirements. Similar reasoning was used to explain why the 
S. pombe profilin, recently shown to be required for cytoki- 
nesis, does not appear to be essential for other processes in- 
volving actin filament formation (Balasubramanian  et al., 
1994). 
Warren et al. Role ofNonmuscle Tropomyosins  705 Figure 8. Cytochalasin B disruption of TM-containing microfilament bundles is more severe in stable lines expressing hTM3. CG3 staining 
for endogenous TM reveals the extent of microfilament rearrangement  caused by a 30-min treatment  of 1.0/zg/ml cytochalasin B. The 
nonexpressing control line, hTM3C32 (A), was the most resistant,  with intact stress fibers still remaining in most cells. With increasing 
expression of hTM3 in lines hTM3CI5 (B), hTM3C36 (C), and hTM3C'/3 (D), however, the disruption was increasingly more extensive. 
Bar,  10 #m. 
In  apparent  contrast  to  proposals  that  nonmuscle  TM 
serves to protect actin filament structures in the cell, we have 
found that stable overexpression of hTM3, hTM5, hTM5/3, 
or hTM5/2 does not stabilize microfilaments. In fact, with 
increasing levels of hTM expression, CHO cell actin struc- 
tures were increasingly less resistant to cytochalasin B (Fig. 
8). The disparity between the in vitro-based predictions and 
our study can easily be reconciled by considering TM as an 
essential tool used by caldesmon,  and possibly other pro- 
teins, in the stabilization of actin filaments. Tropomyosin it- 
self may not stabilize as effectively on its own. In vitro, cal- 
desmon greatly enhances the ability of TM to bind to actin 
(Yamashiro-Matsumura and Matsumura, 1988; Novy et al., 
1993a), and to protect against the severing activity of gelso- 
lin  (Ishikawa et al.,  1989)  and the cross-linking action of 
filamin (Nomura et al., 1987).  In additional support of the 
working  relationship  of TM  and  caldesmon  in  vivo,  we 
have previously reported that overexpression of an actin-, 
TM-, and Ca2÷/calmodulin-binding fragment of caldesmon 
(CAD39)  stabilized  endogenous  TMs  and  microfilaments 
(Warren et al., 1994). In our hTM-transfected cells, endoge- 
nous caldesmon and TM levels do not change (Figs. 2-4), 
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mal. This may result in a population of filaments not fully 
protected, and, therefore, more susceptible to cytochalasin 
B. Alternatively,  works from previous investigators  (Lal and 
Korn,  1986;  Hitchcock-DeGregori et al., 1988;  Broschat et 
al., 1989) suggest little effect of tropomyosins on the barbed 
end  of actin  filaments,  whereas tropomyosins  are  able  to 
stabilize the pointed end from disassembly. Moreover, it has 
been elegantly  shown that cytochalasins  strongly affect the 
barbed end of actin filaments (for review see Cooper, 1987). 
Thus,  it may  not be too surprising  that overexpression of 
tropomyosins in vivo, in the presence of endogenous actin- 
binding  proteins,  does  not  stabilize  filaments  from cyto- 
chalasins.  However, this possibility still cannot explain the 
more sensitive nature of tropomyosin-overexpressing clones. 
Why  hTM3  lines  are  more  sensitive  to  actin  disrupting 
agents than  hTM5,  hTM5/3,  or hTM5/2  lines is not clear. 
Since the levels of hTM  expression are not vastly  different 
in the three sets of cell lines,  with the exception of high- 
expressing line hTM5C14, the degree of sensitivity may in- 
volve functional isoform differences.  Our previous in vitro 
characterization (Novy et al., 1993a), found that hTM3 had 
a lower affinity for actin and required significantly more cal- 
desmon  to  achieve  half maximal  binding  than  hTM5  or 
hTM5/3, so it is possible that the difference in cell line sensi- 
tivity is related to the actin binding properties of the force- 
expressed TM. 
Another line of support for a stabilizing role for TM has 
emerged from the study of changes that occur with cell trans- 
formation. We and others have correlated the down regula- 
tion of high molecular weight TM isoforms in transformed 
cells  with  the  maintenance  of  the  diminished  microfila- 
ment organization characteristic of the transformed  pheno- 
type (Lin et al., 1984, 1985; Hendricks and Weintraub, 1981; 
Cooper et al.,  1985;  Leavitt et al.,  1986). It is important to 
note, however, that many other actin-binding and cytoskele- 
tal  proteins  are  also  downregulated  upon  transformation. 
These include caldesmon (Novy et al.,  1991; Owada et al., 
1984), gelsolin (Vanderkerckhove  et al., 1990), and vinculin 
(Raz  et  al.,  1986).  The  disorganized  nature  of the  actin 
cytoskeleton in transformed  cells may therefore  be a result 
of a  combined  loss of factors.  Even  in cases  where rein- 
troduction of TM results  in the partial restoration of stress 
fibers (Prasad  et al.,  1993), the role of other,  perhaps  TM- 
dependent,  stabilizing factors cannot be ruled out. 
In summary, our analysis of CHO cells which express wild 
type or chimeric isoforms of hTM lends strong  support  for 
the role of nonmuscle TM in cytokinesis.  We also provide 
direct evidence that TM alone does not stabilize actin fila- 
ments in vivo.  A  search for the specific mechanism of the 
cytokinesis defect is underway, and we are also investigating 
the effects of hTM overexpression on cell motility. 
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